The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
Abstract Background There is no known effective treatment strategy to prevent relapses and avert permanent neurological sequelae in opsoclonus–myoclonus syndrome (OMS). To describe the treatment strategy that reduced relapses and led to remission of OMS without permanent neurological sequelae. Metho...
Saved in:
Main Authors: | Fang He, Miriam Kessi, Ciliu Zhang, Jing Peng, Fei Yin, Lifen Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Italian Journal of Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13052-025-01875-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opsoclonus-myoclonus syndrome in the course of teratoma: a case report
by: Mateusz Szczupak, et al.
Published: (2025-01-01) -
Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?
by: Ahmet Kaya, et al.
Published: (2024-12-01) -
The case of Kinsburn’s Encephalopathy in a child with neuroblastoma of posterior mediastinum
by: T.I. Stetsenko, et al.
Published: (2024-02-01) -
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
by: Jeet Hemantkumar Patel, et al.
Published: (2020-01-01) -
Unexpected cause of headache in a patient with Noonan syndrome: aseptic meningitis
by: Hacer Efnan Melek Arsoy, et al.
Published: (2024-09-01)